Youngy Health Co., Ltd.
Simbol: 300247.SZ
SHZ
2.97
CNYTržna cena danes
68.1562
Razmerje P/E
4.6551
Razmerje PEG
2.39B
Kapaciteta MRK
- 0.00%
Donos DIV
Youngy Health Co., Ltd. (300247-SZ) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 493.1 | 409.3 | 235.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 374 | 341 | 144.3 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 51.8 | 54.3 | 65.6 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 143.9 | 186.6 | 149.2 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 129.2 | 116.5 | 51 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 818 | 766.7 | 501.4 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 224.9 | 246.1 | 259.4 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | -323 | -290.1 | -10.9 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 7 | 3.1 | 1.9 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 451.9 | 416.1 | 214.7 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 403.5 | 420.1 | 520.7 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 47.4 | 52.7 | 52 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 12 | 10.4 | 7 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 2.7 | 3.6 | 2.7 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | -19.1 | -15.9 | 0.1 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 1.7 | 2.4 | 1.9 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 24.5 | 32.9 | 33.2 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 148.9 | 158 | 161.1 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 804 | 804 | 804 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1200.1 | -1226.7 | -1353 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 45.1 | 66.5 | 35.3 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1367.7 | 1345.1 | 1345.1 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1016.8 | 989 | 831.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 55.9 | 39.8 | 29.7 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1072.7 | 1028.8 | 861.1 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 50.9 | 50.9 | 133.4 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 17.3 | 27.4 | 32.1 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | -101.8 | -40.9 | -59.2 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 133.3 | 31.4 | -55.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 28.4 | 22.6 | 18.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -6.7 | -1.9 | -1.1 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -51.9 | -18.9 | 75.4 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | -14.7 | 15.9 | 24.1 | |||||||||||||||||
cash-flows.row.inventory | 0 | -40 | -44 | 3.2 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -3.9 | 7.4 | 47 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -139.1 | -24.3 | 42.3 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.2 | 0.2 | 35.5 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -800.7 | -374.7 | -355.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 805.5 | 256.5 | 368.4 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 19.1 | 55 | 0.5 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 7.6 | -69.3 | 39.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -11.6 | -5.7 | -25 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.9 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -11.6 | -5.7 | -10.8 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -11.6 | -5.7 | -36.7 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 10.1 | -4.5 | -10.1 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -23 | -68.7 | 73.9 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 68.3 | 91.3 | 160 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 91.3 | 160 | 86.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -29.2 | 10.8 | 81 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -46.7 | 4.6 | 72.3 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 529.4 | 463.3 | 526.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 355.5 | 352 | 399.3 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 174 | 111.3 | 127.2 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 132.2 | 119.2 | 112.2 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 487.6 | 471.2 | 511.5 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 7.9 | 2.9 | 2.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 28 | 28.4 | 22.6 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 59.4 | 137.2 | 38.3 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 59.8 | 136.4 | 37.8 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 17.8 | 3.1 | 6.3 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 26.6 | 126.3 | 24.2 |
Pogosto zastavljeno vprašanje
Kaj je Youngy Health Co., Ltd. (300247.SZ) skupna sredstva?
Youngy Health Co., Ltd. (300247.SZ) skupna sredstva so 1221559067.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.332.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.115.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.066.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.130.
Kaj je Youngy Health Co., Ltd. (300247.SZ) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 26582643.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 17332369.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 132173058.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.